Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
415 Capital is a venture capital firm based in Munich, Germany, specializing in breakthrough medical technology (MedTech) innovation. The firm invests in early to commercial-stage MedTech companies across Europe, the United States, and Israel, with a strong focus on cardiovascular and neurovascular diseases. They provide capital, expertise, and market access, supporting entrepreneurs from R&D through commercialization.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is 415 Capital's primary investment focus by sector?
- 415 Capital primarily focuses on the Health Tech & Life Sciences sector, with one portfolio company in this area.
- What is 415 Capital's most recent investment activity?
- 415 Capital made an investment in June 2021, which was their most recent activity recorded.
- Which funding stages does 415 Capital typically invest in?
- 415 Capital has participated in A Round funding stages.
- Can you name a portfolio company of 415 Capital?
- Cardiac Success is a portfolio company of 415 Capital. It is a B2B company founded in 2017, developing a ventricular repair device for heart failure patients.
- What was the funding stage and amount for Cardiac Success?
- Cardiac Success secured an A Round of $6.82M.
- Where is 415 Capital headquartered?
- 415 Capital is headquartered in Germany.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2018 |
|---|